Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Tax Provisions (2020 - 2025)

Historic Tax Provisions for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $664000.0.

  • Bioventus' Tax Provisions rose 1273.34% to $664000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 13276.2%. This contributed to the annual value of -$5.3 million for FY2024, which is 632705.88% down from last year.
  • Per Bioventus' latest filing, its Tax Provisions stood at $664000.0 for Q3 2025, which was up 1273.34% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Bioventus' Tax Provisions ranged from a high of $1.7 million in Q3 2021 and a low of -$29.5 million during Q4 2022
  • For the 5-year period, Bioventus' Tax Provisions averaged around -$2.6 million, with its median value being -$73000.0 (2021).
  • In the last 5 years, Bioventus' Tax Provisions skyrocketed by 165818.18% in 2021 and then crashed by 693013.7% in 2022.
  • Over the past 5 years, Bioventus' Tax Provisions (Quarter) stood at -$2.7 million in 2021, then plummeted by 302.31% to -$11.0 million in 2022, then skyrocketed by 93.16% to -$750000.0 in 2023, then soared by 173.33% to $550000.0 in 2024, then rose by 20.73% to $664000.0 in 2025.
  • Its last three reported values are $664000.0 in Q3 2025, $1.0 million for Q2 2025, and -$95000.0 during Q1 2025.